However, if TP53 was silenced concomitant with initiation of KRASG12D expression, inhibition of autophagy enhanced glucose uptake and enrichment of anabolic pathways, promoted PDA progression, and decreased mouse survival [79]. This evidence concerns the gene TP53 and Patent ductus arteriosus.